e-Article – 부산대학교 도서관

e-Article

replayBack to search results

searchSearch screen

A soluble LAG-3 protein (eftilagimod alpha) and an anti-PD-L1 antibody (avelumab) tested in a phase I trial: a new combination in immuno-oncology

Document Type

Article

Author

Al-Batran, S.-E.; Mueller, D.W.; Rafiyan, M.-R.; Kiselicki, D.; Atmaca, A.; Habibzada, T.; Mueller, C.; Brignone, C.; Triebel, F.; Loose, M.; Schaaf, M.; Sookthai, D.; Eickhoff, R.; Jaeger, E.; Goetze, T.O.

Source

In ESMO Open October 2023 8(5)

Subject

Phase I Trials

Language

ISSN

2059-7029

Online Access

Full Text (ScienceDirect 종량제) Full Text (Clinical Key) Full Text (ScienceDirect O/A) Web of Science JCR 저널정보 Scopus Find it@PNU

이메일